A landmark 2023 cardiovascular outcomes trial demonstrated that semaglutide reduced major adverse cardiac events by 20%, sparking questions about whether this GLP-1 receptor agonist actively lowers cholesterol or simply works through other mechanisms
As microbiome research progresses, a deeper understanding of its complex interactions with the immune system and other physiological processes will pave the way for more targeted, personalized microbiome-based treatments, which may eventually complement or replace conventional therapies for gastrointestinal diseases
She knows she was a body-positivity symboland I think she still is
Thats why FEP Blue Focus members can get rewarded for having theirs
Another possible symptom is skin sensitivity to scratches, where even the smallest scratch causes blood vessels to rupture, resulting in bleeding at that site
Low-dose Ozempic, aka microdose Ozempic, remains an area of ongoing research, with emerging benefits in Alzheimers disease, Mental health and longevity